Authors
Loading...
Retrospective analysis shows treatment with hypomethylating agents and venetoclax affects survival rates in AML, highlighting minimal residual disease significance.
Croker et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: